Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HSK31858 for airway mucus hypersecretion in chronic inflammatory airway diseases
CTR20244195Phase 2Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK31858 in bronchiectasis, chronic obstructive pulmonary disease (COPD), asthma, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Nov 2024; status: completed.
02
Drugs
HSK31858
03
Conditions
bronchiectasischronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on CTR20244195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244195.